MILLER EDWARD (General Counsel) sold 1.6% of their position (106.00 shares) of KALARIS THERAPEUTICS, INC. on the open market
Open‑market sale worth $1.1K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/24/2025ACC: 0000950170-25-025630
Officer· General Counsel
Since Jul 2020
-106.00
Net shares
Net seller
$1.1K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
106.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−106.00
Price / share
$10.08
Trade value
$1.07K
% of position
1.6%
2/21/2025
6.62K→6.52K
Total
Net shares
−106.00
Net value
-$1.07K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/21/2025 | S · Sale | −106.00 | $10.08 | $1.07K | 1.6% | 6.62K | 6.52K |
| Total | −106.00 | -$1.07K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned15.06K
Total
15.06K indirect15.06K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 15.06K | Indirect |
| Total | 15.06K | 15.06K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported